Indicated for: cancer
Route of administration: injectable / infusion
Substance: cyclophosphamide (alkylating antineoplastic agent)
ATC: L01AA01 (Antineoplastic and immunomodulating agents | Alkylating agents | Nitrogen mustard analogues)
Cyclophosphamidum is a chemotherapy drug used to treat various types of cancer, including lymphomas, leukemias, and breast cancer. It belongs to the class of alkylating agents and works by destroying cancer cells and preventing them from dividing.
The medication is administered intravenously or orally, depending on the type and stage of cancer. It is often used in combination with other chemotherapy drugs to enhance treatment effectiveness.
Side effects may include nausea, vomiting, hair loss, fatigue, and an increased risk of infections. In rare cases, it may cause kidney or bladder toxicity. It is important to follow all medical recommendations to minimize risks.
Consult your doctor to discuss the benefits and risks of treatment with Cyclophosphamidum. Close monitoring is essential during treatment to manage potential side effects.